WED-280 - INTEGRIS-PSC phase 2a study: evaluating the safety, tolerability, and pharmacokinetics of bexotegrast (PLN-74809) in participants with primary sclerosing cholangitis

Journal article

Peer reviewed

Gideon Hirschfield, Palak Trivedi, Cynthia Levy, Christoph Schramm, Kris Kowdley, Michael Trauner, Richard Pencek, Hardean Achneck and Eric Lefebvre

Journal of hepatology, Vol.78, pp.S356-S356

2023-06

Metrics

1 Record Views

Title: WED-280 - INTEGRIS-PSC phase 2a study: evaluating the safety, tolerability, and pharmacokinetics of bexotegrast (PLN-74809) in participants with primary sclerosing cholangitis
Creators: Gideon Hirschfield
Palak Trivedi
Cynthia Levy
Christoph Schramm
Kris Kowdley
Michael Trauner
Richard Pencek
Hardean Achneck
Eric Lefebvre
Publication Details: Journal of hepatology, Vol.78, pp.S356-S356
Publisher: Elsevier B.V
Academic Unit: UMMG Dept of Medicine - Hepatology; Miller School of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031921591802976